| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | Woolson Daniel President | Sale | -2,123 | -8.63%22,479 | $132.21 | $280,685 | View SEC filing | |
| 2026-05-13 | Greenberg David C. Director | Sale | -2,424 | -23.34%7,960 | $122.91 | $297,934 | View SEC filing | |
| 2025-11-25 | Woolson Daniel VP, GM-Infusion Capital | Sale | -2,897 | -20.41%11,297 | $152.35 | $441,364 | View SEC filing | |
| 2025-11-12 | Sanzone Virginia Ruth VP, General Counsel | Sale | -930 | -14.56%5,456 | $142.34 | $132,381 | View SEC filing | |
| 2025-11-12 | FINNEY ELISHA W Director | Sale | -1,285 | -24.34%3,995 | $140.42 | $180,440 | View SEC filing | |
| 2025-08-27 | Greenberg David C. Director | Purchase | +1,200 | +17.75%7,960 | $126.42 | $151,698 | View SEC filing | |
| 2025-08-14 | Jain Vivek Chairman and CEO | Purchase | +21,929 | +20.26%130,149 | $112.84 | $2,474,375 | View SEC filing | |
| 2025-05-30 | Sanzone Virginia Ruth VP, General Counsel | Sale | -700 | -9.88%6,386 | $133.62 | $93,537 | View SEC filing | |
| 2025-05-28 | Voigtlander Christian B. Chief Operating Officer | Sale | -9,930 | -41.79%6,088 | $129.75 | $1,288,371 | View SEC filing | |
| 2025-05-23 | Voigtlander Christian B. Chief Operating Officer | Sale | -9,918 | -47.09%4,903 | $130.02 | $1,289,502 | View SEC filing | |
| 2025-05-21 | Voigtlander Christian B. Chief Operating Officer | Sale | -9,788 | -53.29%3,711 | $135.05 | $1,321,840 | View SEC filing | |
| 2025-05-20 | FINNEY ELISHA W Director | Sale | -600 | -15.58%3,252 | $138.92 | $83,353 | View SEC filing | |
| 2025-05-19 | Voigtlander Christian B. Chief Operating Officer | Sale | -11,110 | -69.93%2,389 | $139.00 | $1,544,314 | View SEC filing | |
| 2025-05-15 | Sousa Ben Chief Information Officer | Sale | -2,000 | -80.68%479 | $137.36 | $274,714 | View SEC filing | |
| 2025-05-15 | Voigtlander Christian B. Chief Operating Officer | Sale | -11,111 | -69.93%2,389 | $137.10 | $1,523,301 | View SEC filing | |
| 2025-05-13 | Greenberg David C. Director | Sale | -1,942 | -22.32%6,760 | $143.66 | $278,992 | View SEC filing | |
| 2025-01-02 | Jain Vivek Chairman and CEO | Sale | -1,373 | -1.30%104,593 | $155.48 | $213,474 | View SEC filing | |
| 2024-12-06 | Woolson Daniel VP, GM-Infusion Capital | Sale | -2,241 | -17.10%10,866 | $156.25 | $350,158 | View SEC filing | |
| 2024-12-02 | Jain Vivek Chairman and CEO | Sale | -12,000 | -10.29%104,593 | $162.91 | $1,954,935 | View SEC filing | |
| 2024-11-27 | Voigtlander Christian B. Chief Operating Officer | Sale | -1,430 | -100.00%0 | $158.00 | $225,936 | View SEC filing | |
| 2024-11-27 | Greenberg David C. Director | Sale | -972 | -16.18%5,037 | $158.11 | $153,683 | View SEC filing | |
| 2024-11-26 | Voigtlander Christian B. Chief Operating Officer | Sale | -9,681 | -100.00%0 | $161.13 | $1,559,917 | View SEC filing | |
| 2024-11-04 | Jain Vivek Chairman and CEO | Sale | -12,000 | -10.29%104,593 | $171.84 | $2,062,136 | View SEC filing | |
| 2024-10-01 | Jain Vivek Chairman and CEO | Sale | -12,000 | -10.29%104,593 | $178.46 | $2,141,580 | View SEC filing | |
| 2024-09-03 | Jain Vivek Chairman and CEO | Sale | -12,000 | -3.47%104,593 | $163.46 | $1,961,540 | View SEC filing |
1-25 of 597
